Inventor · disambiguated record
Shengfang Jin
Also filed as: JIN SHENGFANG
8 granted patents·13 pending applications·82 citations·filing 1999–2024
87Inventor score
Files withAGIOS PHARMACEUTICALS INC5MILLENNIUM PHARM INC4DANG LEONARD LUAN C3ORE PHARMACEUTICALS INC2SERVIER PHARMACEUTICALS LLC2
Top patents by PatentIndex Score
21 records- 0194US10610125B2Methods and compositions for cell-proliferation-related disordersAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Apr 7, 2020·9 cites·12 claims
- 0290US9434979B2Methods and compositions for cell-proliferation-related disordersSU SHIN-SAN MICHAEL·Filed 2012·Granted Sep 6, 2016·7 cites·7 claims
- 0390US8883438B2Method for diagnosing cell proliferation disorders having a neoactive mutation at residue 97 of isocitrate dehydrogenase 1CANTLEY LEWIS C·Filed 2012·Granted Nov 11, 2014·18 cites·12 claims
- 0490US2025378926A1Methods and compositions for cell-proliferation-related disordersSERVIER PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0588US9982309B2Method for treating cell proliferation related disordersAGIOS PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·3 cites·14 claims
- 0683US2024071588A1Methods and compositions for cell-proliferation-related disordersSERVIER PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 0782US6933105B2Resistance sequences and uses thereofMILLENNIUM PHARM INC·Filed 2001·Granted Aug 23, 2005·12 cites·33 claims
- 0871US2020281501A1Methods and compositions for cell-proliferation-related disordersAGIOS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0970US10711314B2Methods for diagnosing IDH-mutant cell proliferation disordersAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Jul 14, 2020·0 cites·8 claims
- 1069US2015240286A1Methods and compositions for cell-proliferation-related disordersDANG LEONARD LUAN C·Filed 2014·Application pending·0 cites
- 1163US2013288284A1Methods and compositions for cell-proliferation-related disordersDANG LEONARD LUAN C·Filed 2012·Application pending·0 cites
- 1263US2014187435A1Methods and compositions for cell-proliferation-related disordersDANG LEONARD LUAN C·Filed 2013·Application pending·0 cites
- 1361US2004091948A1Chk1 and uses thereofMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 1458US6723498B1Chk1 and uses thereofMILLENNIUM PHARM INC·Filed 1999·Granted Apr 20, 2004·18 cites·38 claims
- 1556US2009012052A1Method for treating er+ breast cancerORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1655US2024276957A1Methods of treatment with aminolevulinic acid synthase 2 (alas2) modulatorsAGIOS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1755US2012121515A1Methods and compositions for cell-proliferation-related disordersDANG LENNY·Filed 2010·Application pending·0 cites
- 1848US2010029734A1Methods for breast cancer screening and treatmentORE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1947US6423494B1DR6 and uses thereofMILLENNIUM PHARM INC·Filed 1999·Granted Jul 23, 2002·15 cites·15 claims
- 2045US2008132474A1Breast cancer screening and treatment methodsGENE LOGIC INC·Filed 2007·Application pending·0 cites
- 2144US2012041070A1Methods of treating cancer having an aberrant egfr or kras genotypeJIN SHENGFANG·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shengfang Jin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →